Boehringer Ingelheim Canada Ltd.
Registration:
3
of
5
(2023-06-01
to
2023-08-15)
Policies or Program
- Arranging meetings to brief government officials on the business of Boehringer Ingelheim Canada Ltd.
- Pharmaceutical pricing policy arising from the jurisdiction of the patented medicine prices review board (PMPRB).